This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2005 Dec 1;11(23):8226-9.

doi: 10.1158/1078-0432.CCR-05-2035.

The therapeutic implications of intratumoral regulatory T cells

Glenn Dranoff¹

Affiliations

PMID: 16322278
DOI: 10.1158/1078-0432.CCR-05-2035

Comment

The therapeutic implications of intratumoral regulatory T cells

Glenn Dranoff. Clin Cancer Res. 2005.

. 2005 Dec 1;11(23):8226-9.

doi: 10.1158/1078-0432.CCR-05-2035.

Author

Glenn Dranoff¹

Affiliation

¹ Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.

PMID: 16322278
DOI: 10.1158/1078-0432.CCR-05-2035

No abstract available

PubMed Disclaimer

Comment on

The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer.
Wolf D, Wolf AM, Rumpold H, Fiegl H, Zeimet AG, Muller-Holzner E, Deibl M, Gastl G, Gunsilius E, Marth C. Wolf D, et al. Clin Cancer Res. 2005 Dec 1;11(23):8326-31. doi: 10.1158/1078-0432.CCR-05-1244. Clin Cancer Res. 2005. PMID: 16322292

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems
Medical
- MedlinePlus Health Information